Our Blog

Rachael Ray Talks to Dr. Khanna

June 18, 2020

Dr. Chand Khanna, joined Rachael Ray and internal medicine specialist Dr. William Li to talk about the bridge between animal and human health, and how research for one can positively impact the other

Improving Survival Rates in Septic Patients

June 11, 2020

Sepsis is the result of an infection that enters the bloodstream and causes a severe inflammatory reaction. It can lead to many alterations around the body that can cause significant difficulty in the diagnosis and treatment of the underlying infection. Ethos Discovery hopes that its research will contribute to an improvement in patient survival rates, which would not only be beneficial to veterinary patients, but to human patients as well.

How Hemangiosarcoma Broke Our Hearts

May 27, 2020

We hope that Dakota’s story helps those who are unfamiliar with the rapid progression of Hemangiosarcoma to better understand it.

About Intestinal Dysbiosis and why it is a Priority for Ethos Discovery

April 29, 2020

Intestinal dysbiosis is an alteration in the composition and/or richness of the normal bacteria that are found in the gastrointestinal tract (microbiota). The effect of intestinal dysbiosis on the progression of various diseases is currently lacking in both human and veterinary medicine. Ethos Discovery now asks what the influence of intestinal dysbiosis is on a variety of non-GI diseases in veterinary patients.

How Clinical Trials Have Intersected with my Practice of Clinical Medicine

March 25, 2020

Our President Dr. Chand Khanna shares his thoughts on his career as a practicing veterinary oncologiest, and his approach to innovation and clinical trials. The option of therapeutics only available through clinical trials has been a key feature of his practice of clinical medicine which has delivered many favorable intended and unintended consequences.

A Necessary Shift in Perspective: A First Step Towards Curative Outcomes in Veterinary Oncology

March 18, 2020

Ethos Discovery seeks to deliver curative outcomes for pet animals with cancer. Given that the term "cure" has been historically avoided, we do not document or recognize curative outcomes when they occur. As a first step towards raising cancer survivorship, a change in perspective and our assessment of existing data is needed.

Precision Medicine and Canine Hemangiosarcoma

April 30, 2019

There are limited therapeutic options for the treatment of hemangiosarcoma, with none currently providing a significant opportunity for long-term survival. Ethos Discovery’s previous work in hemangiosarcoma has taught us that hemangiosarcoma is not a single cancer, but rather at least four different subtypes of cancer.